Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF

Background and AimsPatients with cirrhosis and acute-on-chronic liver failure (ACLF) have immunosuppression, indicated by an increase in circulating immune-deficient monocytes. The aim of this study was to investigate simultaneously the major blood-immune cell subsets in these patients.Material and...

Full description

Bibliographic Details
Main Authors: Emmanuel Weiss, Pierre de la Grange, Mylène Defaye, Juan José Lozano, Ferrán Aguilar, Pushpa Hegde, Ariane Jolly, Lucile Moga, Sukriti Sukriti, Banwari Agarwal, Haqeeqat Gurm, Marion Tanguy, Johanne Poisson, Joan Clària, Paer-Selim Abback, Axel Périanin, Gautam Mehta, Rajiv Jalan, Claire Francoz, Pierre-Emmanuel Rautou, Sophie Lotersztajn, Vicente Arroyo, François Durand, Richard Moreau
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.619039/full
id doaj-08bb7077b5d446efbff237f3b2fd3c80
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Emmanuel Weiss
Emmanuel Weiss
Emmanuel Weiss
Pierre de la Grange
Mylène Defaye
Juan José Lozano
Ferrán Aguilar
Pushpa Hegde
Ariane Jolly
Lucile Moga
Lucile Moga
Sukriti Sukriti
Banwari Agarwal
Haqeeqat Gurm
Marion Tanguy
Johanne Poisson
Joan Clària
Joan Clària
Joan Clària
Joan Clària
Paer-Selim Abback
Axel Périanin
Gautam Mehta
Gautam Mehta
Gautam Mehta
Rajiv Jalan
Rajiv Jalan
Claire Francoz
Pierre-Emmanuel Rautou
Pierre-Emmanuel Rautou
Sophie Lotersztajn
Vicente Arroyo
François Durand
François Durand
Richard Moreau
Richard Moreau
Richard Moreau
spellingShingle Emmanuel Weiss
Emmanuel Weiss
Emmanuel Weiss
Pierre de la Grange
Mylène Defaye
Juan José Lozano
Ferrán Aguilar
Pushpa Hegde
Ariane Jolly
Lucile Moga
Lucile Moga
Sukriti Sukriti
Banwari Agarwal
Haqeeqat Gurm
Marion Tanguy
Johanne Poisson
Joan Clària
Joan Clària
Joan Clària
Joan Clària
Paer-Selim Abback
Axel Périanin
Gautam Mehta
Gautam Mehta
Gautam Mehta
Rajiv Jalan
Rajiv Jalan
Claire Francoz
Pierre-Emmanuel Rautou
Pierre-Emmanuel Rautou
Sophie Lotersztajn
Vicente Arroyo
François Durand
François Durand
Richard Moreau
Richard Moreau
Richard Moreau
Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
Frontiers in Immunology
myeloid cells
innate lymphoid cells
adaptive immune cells
sepsis
organ failure
immunotherapies
author_facet Emmanuel Weiss
Emmanuel Weiss
Emmanuel Weiss
Pierre de la Grange
Mylène Defaye
Juan José Lozano
Ferrán Aguilar
Pushpa Hegde
Ariane Jolly
Lucile Moga
Lucile Moga
Sukriti Sukriti
Banwari Agarwal
Haqeeqat Gurm
Marion Tanguy
Johanne Poisson
Joan Clària
Joan Clària
Joan Clària
Joan Clària
Paer-Selim Abback
Axel Périanin
Gautam Mehta
Gautam Mehta
Gautam Mehta
Rajiv Jalan
Rajiv Jalan
Claire Francoz
Pierre-Emmanuel Rautou
Pierre-Emmanuel Rautou
Sophie Lotersztajn
Vicente Arroyo
François Durand
François Durand
Richard Moreau
Richard Moreau
Richard Moreau
author_sort Emmanuel Weiss
title Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
title_short Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
title_full Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
title_fullStr Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
title_full_unstemmed Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLF
title_sort characterization of blood immune cells in patients with decompensated cirrhosis including aclf
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-02-01
description Background and AimsPatients with cirrhosis and acute-on-chronic liver failure (ACLF) have immunosuppression, indicated by an increase in circulating immune-deficient monocytes. The aim of this study was to investigate simultaneously the major blood-immune cell subsets in these patients.Material and MethodsBlood taken from 67 patients with decompensated cirrhosis (including 35 critically ill with ACLF in the intensive care unit), and 12 healthy subjects, was assigned to either measurements of clinical blood counts and microarray (genomewide) analysis of RNA expression in whole-blood; microarray (genomewide) analysis of RNA expression in blood neutrophils; or assessment of neutrophil antimicrobial functions.ResultsSeveral features were found in patients with ACLF and not in those without ACLF. Indeed, clinical blood count measurements showed that patients with ACLF were characterized by leukocytosis, neutrophilia, and lymphopenia. Using the CIBERSORT method to deconvolute the whole-blood RNA-expression data, revealed that the hallmark of ACLF was the association of neutrophilia with increased proportions of macrophages M0-like monocytes and decreased proportions of memory lymphocytes (of B-cell, CD4 T-cell lineages), CD8 T cells and natural killer cells. Microarray analysis of neutrophil RNA expression revealed that neutrophils from patients with ACLF had a unique phenotype including induction of glycolysis and granule genes, and downregulation of cell-migration and cell-cycle genes. Moreover, neutrophils from these patients had defective production of the antimicrobial superoxide anion.ConclusionsGenomic analysis revealed that, among patients with decompensated cirrhosis, those with ACLF were characterized by dysregulation of blood immune cells, including increases in neutrophils (that had a unique phenotype) and macrophages M0-like monocytes, and depletion of several lymphocyte subsets (including memory lymphocytes). All these lymphocyte alterations, along with defective neutrophil superoxide anion production, may contribute to immunosuppression in ACLF, suggesting targets for future therapies.
topic myeloid cells
innate lymphoid cells
adaptive immune cells
sepsis
organ failure
immunotherapies
url https://www.frontiersin.org/articles/10.3389/fimmu.2020.619039/full
work_keys_str_mv AT emmanuelweiss characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT emmanuelweiss characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT emmanuelweiss characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT pierredelagrange characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT mylenedefaye characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT juanjoselozano characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT ferranaguilar characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT pushpahegde characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT arianejolly characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT lucilemoga characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT lucilemoga characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT sukritisukriti characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT banwariagarwal characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT haqeeqatgurm characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT mariontanguy characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT johannepoisson characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT joanclaria characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT joanclaria characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT joanclaria characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT joanclaria characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT paerselimabback characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT axelperianin characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT gautammehta characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT gautammehta characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT gautammehta characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT rajivjalan characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT rajivjalan characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT clairefrancoz characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT pierreemmanuelrautou characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT pierreemmanuelrautou characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT sophielotersztajn characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT vicentearroyo characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT francoisdurand characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT francoisdurand characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT richardmoreau characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT richardmoreau characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
AT richardmoreau characterizationofbloodimmunecellsinpatientswithdecompensatedcirrhosisincludingaclf
_version_ 1724284039818379264
spelling doaj-08bb7077b5d446efbff237f3b2fd3c802021-02-05T07:45:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011110.3389/fimmu.2020.619039619039Characterization of Blood Immune Cells in Patients With Decompensated Cirrhosis Including ACLFEmmanuel Weiss0Emmanuel Weiss1Emmanuel Weiss2Pierre de la Grange3Mylène Defaye4Juan José Lozano5Ferrán Aguilar6Pushpa Hegde7Ariane Jolly8Lucile Moga9Lucile Moga10Sukriti Sukriti11Banwari Agarwal12Haqeeqat Gurm13Marion Tanguy14Johanne Poisson15Joan Clària16Joan Clària17Joan Clària18Joan Clària19Paer-Selim Abback20Axel Périanin21Gautam Mehta22Gautam Mehta23Gautam Mehta24Rajiv Jalan25Rajiv Jalan26Claire Francoz27Pierre-Emmanuel Rautou28Pierre-Emmanuel Rautou29Sophie Lotersztajn30Vicente Arroyo31François Durand32François Durand33Richard Moreau34Richard Moreau35Richard Moreau36Assistance Publique—Hôpitaux de Paris (AP-HP), Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU Parabol, AP-HP Nord, Paris, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainGenoSplice, Paris, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceCIBERehd, Barcelona, SpainEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceGenoSplice, Paris, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceAssistance Publique—Hôpitaux de Paris (APHP), Service d’Hépatologie & Réanimation Hépato Digestive, Hôpital Beaujon, Clichy, FranceDepartment of Research, Institute of Liver and Biliary Sciences, New Delhi, IndiaLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, United KingdomLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, United KingdomUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainCIBERehd, Barcelona, SpainHospital Clínic-August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain0Universitat de Barcelona, Barcelona, SpainUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, United Kingdom1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom2Faculty of Life Sciences & Medicine, King’s College London, London, United KingdomEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainLiver Failure Group, Institute for Liver and Digestive Health, University College London, London, United KingdomAssistance Publique—Hôpitaux de Paris (APHP), Service d’Hépatologie & Réanimation Hépato Digestive, Hôpital Beaujon, Clichy, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceAssistance Publique—Hôpitaux de Paris (APHP), Service d’Hépatologie & Réanimation Hépato Digestive, Hôpital Beaujon, Clichy, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceAssistance Publique—Hôpitaux de Paris (APHP), Service d’Hépatologie & Réanimation Hépato Digestive, Hôpital Beaujon, Clichy, FranceUniversité de Paris, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche sur l’Inflammation (CRI), Paris, FranceEuropean Foundation for the study of Chronic Liver Failure (EF-Clif), European Association for the Study of Chronic Liver Failure (EASL-CLIF) Consortium and Grifols Chair, Barcelona, SpainAssistance Publique—Hôpitaux de Paris (APHP), Service d’Hépatologie & Réanimation Hépato Digestive, Hôpital Beaujon, Clichy, FranceBackground and AimsPatients with cirrhosis and acute-on-chronic liver failure (ACLF) have immunosuppression, indicated by an increase in circulating immune-deficient monocytes. The aim of this study was to investigate simultaneously the major blood-immune cell subsets in these patients.Material and MethodsBlood taken from 67 patients with decompensated cirrhosis (including 35 critically ill with ACLF in the intensive care unit), and 12 healthy subjects, was assigned to either measurements of clinical blood counts and microarray (genomewide) analysis of RNA expression in whole-blood; microarray (genomewide) analysis of RNA expression in blood neutrophils; or assessment of neutrophil antimicrobial functions.ResultsSeveral features were found in patients with ACLF and not in those without ACLF. Indeed, clinical blood count measurements showed that patients with ACLF were characterized by leukocytosis, neutrophilia, and lymphopenia. Using the CIBERSORT method to deconvolute the whole-blood RNA-expression data, revealed that the hallmark of ACLF was the association of neutrophilia with increased proportions of macrophages M0-like monocytes and decreased proportions of memory lymphocytes (of B-cell, CD4 T-cell lineages), CD8 T cells and natural killer cells. Microarray analysis of neutrophil RNA expression revealed that neutrophils from patients with ACLF had a unique phenotype including induction of glycolysis and granule genes, and downregulation of cell-migration and cell-cycle genes. Moreover, neutrophils from these patients had defective production of the antimicrobial superoxide anion.ConclusionsGenomic analysis revealed that, among patients with decompensated cirrhosis, those with ACLF were characterized by dysregulation of blood immune cells, including increases in neutrophils (that had a unique phenotype) and macrophages M0-like monocytes, and depletion of several lymphocyte subsets (including memory lymphocytes). All these lymphocyte alterations, along with defective neutrophil superoxide anion production, may contribute to immunosuppression in ACLF, suggesting targets for future therapies.https://www.frontiersin.org/articles/10.3389/fimmu.2020.619039/fullmyeloid cellsinnate lymphoid cellsadaptive immune cellssepsisorgan failureimmunotherapies